• Beta-2 Glycoprotein 1 Antibody, IgM
  • Entamoeba histolytica, Antibody, IgG
  • Leishmania (Visceral Leishmaniasis) Antibody, IgG
  • Immunoglobulin Gene Rearrangement (B-Cell Clonality), Bone Marrow
  • Catecholamine Fractionation, Plasma
  • Herpesvirus 6 (HHV-6), Molecular Detection, Plasma
  • Hepatitis A Virus (HAV) by PCR
  • Integrin Subunit Beta 3 (ITGB3) Gene Mutation Analysis
  • Beta-Galactosidase, Leukocytes
  • Fecal Fat
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /BCR-ABL Mutation Analysis for Tyrosine Kinase Inhibitor Resistance
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

BCR-ABL Mutation Analysis for Tyrosine Kinase Inhibitor Resistance
Medical Test

Interpretation
Access to BCR-ABL Mutation Analysis for Tyrosine Kinase Inhibitor Resistance is restricted.